A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (NCT06226883)

🧪 Interventions in This Study

• Placebo (DRUG)
• MORF-057 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (225 Sites)

Showing the first 25 of 225 sites.

• Gastro Care Institute — Lancaster, California
• Infinity Clinical Research — San Diego, California
• Peak Gastroenterology Associates - Colorado Springs — Colorado Springs, Colorado
• Clinical Research of Osceola — Kissimmee, Florida
• Bioresearch Partner-Kendale Lakes — Miami, Florida
• Endoscopic Research Inc — Orlando, Florida
• Tropical Clinical Trials — Palmetto Bay, Florida
• Atlanta Gastroenterology Specialists, PC — Atlanta, Georgia
• Atlanta Gastroenterology Associates (Part of United Digestive) — Atlanta, Georgia
• Tandem Clinical Research — Houma, Louisiana
• SSM Health DePaul Hospital- St. Louis — Bridgeton, Missouri
• Las Vegas Clinical Trials — North Las Vegas, Nevada
• Cross Creek Medical Clinic — Fayetteville, North Carolina
• Peters Medical Research — High Point, North Carolina
• Wake Research Associates — Raleigh, North Carolina
• Palmetto Gastroenterology Clinical Research — Summerville, South Carolina
• Gastrointestinal Associates of Northeast Tennessee — Johnson City, Tennessee
• GI Alliance - Cedar Park — Cedar Park, Texas
• North Texas Gastroenterology — Denton, Texas
• The University of Texas Health Science Center at Houston — Houston, Texas
• Prime Clinical Research - Lewisville — Lewisville, Texas
• Prime Clinical Research — Mansfield, Texas
• Tyler Research Institute, LLC — Tyler, Texas
• Care Access Research - Ogden — Ogden, Utah
• Gastroenterology Associates of Central Virginia — Lynchburg, Virginia

📞 Contact the Study Coordinator

Phone: (317) 615-4559

Email: LillyTrials@Lilly.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Inflammatory Bowel Diseases

• Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care — Vancouver, British Columbia
• PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial — Ottawa, Ontario
• A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy — Baltimore, Maryland
• Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD) — Ann Arbor, Michigan
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Lancaster, California
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC — Sun City, Arizona

Explore by condition: All Inflammatory Bowel Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.